Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ: WGS )

0.2966 -0.0048 (-1.59%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,520,496
Open 0.3050
Bid (Size) 0.2821 (2)
Ask (Size) 0.2966 (18)
Prev. Close 0.3014
Today's Range 0.2800 - 0.3212
52wk Range 0.2720 - 0.5427
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Shares of GeneDx Dropped Wednesday
The potential of a reverse split concerned investors. 
Via The Motley Fool
Why Citi Trends Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers U.S. Xpress Enterprises, Inc. (NYSE: USX) shares surged 298% to $5.97 after Knight-Swift Transportation agreed to acquire the company for $6.15 per share. 
Via Benzinga

Performance

YTD
-14.28%
-14.28%
1 Month
-38.91%
-38.91%
3 Month
-14.28%
-14.28%
6 Month
-14.28%
-14.28%
1 Year
-14.28%
-14.28%

More News

Read More
First Majestic Silver, Immatics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
GeneDx Holdings's Earnings: A Preview
Via Benzinga
GeneDx Announces Progress on GUARDIAN Study and Promise of Early Genomic Testing to End Rare Disease “Diagnostic Odyssey”
From GeneDx Holdings Corp.
Via Globe NewsWire
The 7 Worst Stocks to Buy Now
Via InvestorPlace
GeneDx Presents New Data at ACMG Demonstrating the Benefits of Exome Sequencing Over Chromosomal Microarray
From GeneDx Holdings Corp.
Via Globe NewsWire
GeneDx Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
From GeneDx Holdings Corp.
Via Globe NewsWire
GeneDx to Participate in the Cowen 43rd Annual Healthcare Conference
From GeneDx Holdings Corp.
Via Globe NewsWire
GeneDx honors Rare Disease Day and announces presentations and research at the 2023 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting
From GeneDx Holdings Corp.
Via Globe NewsWire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Why Quoin Pharmaceuticals Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
GeneDx to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, March 14th, 2023
From GeneDx Holdings Corp.
Via Globe NewsWire
Why Owlet Shares Are Trading Higher By Over 45%; Here Are 20 Stocks Moving Premarket
Via Benzinga
JD.com And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
GeneDx Rare Disease Data Demonstrates Utility in Drug Candidate Identification for Common Diseases
From GeneDx Holdings Corp.
Via Globe NewsWire
Catalent, Faraday Future Intelligent Electric And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
$10 Million Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Buying
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Why Alphabet And Amazon Are Trading Lower; Here Are 20 Stocks Moving Premarket
Via Benzinga
$20 Million Bet On Precigen? Check Out These 4 Penny Stocks Insiders Are Buying
Via Benzinga
GeneDx Announces Closing of Underwritten Public Offering and Concurrent Registered Direct Offering
From GeneDx Holdings Corp.
Via Globe NewsWire
GeneDx Makes Significant Industry-Wide Contributions to New Disease Gene Discovery
From GeneDx Holdings Corp.
Via Globe NewsWire
AUVI Stock Alert: What to Know as Applied UV Takes on Naked Short Sellers
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.